1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Vaccine Contract Manufacturing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 Attenuated
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Inactivated
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Subunit-based
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Toxoid-based
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 DNA-based
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Workflow
7.1 Downstream
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Fill and Finish Operations
7.1.2.2 Analytical and QC studies
7.1.2.3 Packaging
7.1.3 Market Forecast
7.2 Upstream
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Mammalian Expression Systems
7.2.2.2 Bacterial Expression Systems
7.2.2.3 Yeast Expression Systems
7.2.2.4 Baculovirus/Insect Expression Systems
7.2.2.5 Others
7.2.3 Market Forecast
8 Market Breakup by Application
8.1 Human Use
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Veterinary
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Ajinomoto Co. Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Albany Molecular Research Inc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Catalent Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Cobra Biologics Limited (Charles River Laboratories International Inc.)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Cytovance Biologics Inc. (Hepalink USA Inc.)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Fujifilm Holdings Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 ICON plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 IDT Biologika GmbH
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Lonza Group AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Merck KGaA
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Pharmaceutical Product Development LLC
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 PRA Health Sciences Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
List of Figures
Figure 1: Global: Vaccine Contract Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Vaccine Contract Manufacturing Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Vaccine Contract Manufacturing Market: Breakup by Vaccine Type (in %), 2023
Figure 5: Global: Vaccine Contract Manufacturing Market: Breakup by Workflow (in %), 2023
Figure 6: Global: Vaccine Contract Manufacturing Market: Breakup by Application (in %), 2023
Figure 7: Global: Vaccine Contract Manufacturing Market: Breakup by Region (in %), 2023
Figure 8: Global: Vaccine Contract Manufacturing (Attenuated) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Vaccine Contract Manufacturing (Attenuated) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Vaccine Contract Manufacturing (Inactivated) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Vaccine Contract Manufacturing (Inactivated) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Vaccine Contract Manufacturing (Subunit-based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Vaccine Contract Manufacturing (Subunit-based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Vaccine Contract Manufacturing (Toxoid-based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Vaccine Contract Manufacturing (Toxoid-based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Vaccine Contract Manufacturing (DNA-based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Vaccine Contract Manufacturing (DNA-based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Vaccine Contract Manufacturing (Downstream) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Vaccine Contract Manufacturing (Downstream) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Vaccine Contract Manufacturing (Upstream) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Vaccine Contract Manufacturing (Upstream) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Vaccine Contract Manufacturing (Human Use) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Vaccine Contract Manufacturing (Human Use) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Vaccine Contract Manufacturing (Veterinary) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Vaccine Contract Manufacturing (Veterinary) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Vaccine Contract Manufacturing Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Vaccine Contract Manufacturing Industry: SWOT Analysis
Figure 76: Global: Vaccine Contract Manufacturing Industry: Value Chain Analysis
Figure 77: Global: Vaccine Contract Manufacturing Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Vaccine Contract Manufacturing Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Vaccine Type (in Million US$), 2024-2032
Table 3: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Workflow (in Million US$), 2024-2032
Table 4: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Vaccine Contract Manufacturing Market: Competitive Structure
Table 7: Global: Vaccine Contract Manufacturing Market: Key Players